203 related articles for article (PubMed ID: 21034162)
1. Platelet polymorphisms: frequency distribution and association with coronary artery disease in an Indian population.
Ashavaid TF; Todur SP; Kondkar AA; Nair KG; Shalia KK; Dalal JJ; Rajani R; Ponde CK
Platelets; 2011; 22(2):85-91. PubMed ID: 21034162
[TBL] [Abstract][Full Text] [Related]
2. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
Emingil G; Berdeli A; Gürkan A; Han Saygan B; Köse T; Atilla G
J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155
[TBL] [Abstract][Full Text] [Related]
3. An association study of thrombospondin 1 and 2 SNPs with coronary artery disease and myocardial infarction among South Indians.
Ashokkumar M; Anbarasan C; Saibabu R; Kuram S; Raman SC; Cherian KM
Thromb Res; 2011 Oct; 128(4):e49-53. PubMed ID: 21762961
[TBL] [Abstract][Full Text] [Related]
4. The 4G4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosclerosis in patients at high risk for this disease.
Gardemann A; Lohre J; Katz N; Tillmanns H; Hehrlein FW; Haberbosch W
Thromb Haemost; 1999 Sep; 82(3):1121-6. PubMed ID: 10494775
[TBL] [Abstract][Full Text] [Related]
5. [Association of PAI-1 gene polymorphism with prognosis of coronary artery disease].
Zhang AY; Ji XW; Guan LX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):233-5. PubMed ID: 18393255
[TBL] [Abstract][Full Text] [Related]
6. Association of genetic variants of fibrinolytic system with stroke and stroke subtypes.
Babu MS; Prabha TS; Kaul S; Al-Hazzani A; Shafi G; Roy S; Balakrishna N; Jyothy A; Munshi A
Gene; 2012 Mar; 495(1):76-80. PubMed ID: 22240314
[TBL] [Abstract][Full Text] [Related]
7. Myocardial infarction in patients aged less than 40 years. Frequency of BclI polymorphism in the fibrinogen beta-chain gene and plasma fibrinogen.
Lewandowski K; Kwaśnikowski P; Elikowski W; Zawilska K
Kardiol Pol; 2003 Sep; 59(9):205-12. PubMed ID: 14618197
[TBL] [Abstract][Full Text] [Related]
8. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
Abboud N; Ghazouani L; Saidi S; Ben-Hadj-Khalifa S; Addad F; Almawi WY; Mahjoub T
Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
[TBL] [Abstract][Full Text] [Related]
9. A variant of beta fibrinogen is a genetic risk factor for coronary artery disease and myocardial infarction.
Yu Q; Safavi F; Roberts R; Marian AJ
J Investig Med; 1996 Apr; 44(4):154-9. PubMed ID: 8689411
[TBL] [Abstract][Full Text] [Related]
10. Impact of plasminogen activator inhibitor-1 gene polymorphisms on primary membranous nephropathy.
Chen CH; Shu KH; Wen MC; Chen KJ; Cheng CH; Lian JD; Wu MJ; Yu TM; Tsai FJ
Nephrol Dial Transplant; 2008 Oct; 23(10):3166-73. PubMed ID: 18495745
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of C807T mutation of glycoprotein Ia gene among young male survivors of myocardial infarction: a relation with coronary angiography results.
Lewandowski K; Swierczyńska A; Kwaśnikowski P; Elikowski W; Rzeźniczak M
Kardiol Pol; 2005 Aug; 63(2):107-13; discussion114. PubMed ID: 16136407
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis.
Akhter MS; Biswas A; Ranjan R; Meena A; Yadav BK; Sharma A; Saxena R
Clin Appl Thromb Hemost; 2010 Apr; 16(2):184-8. PubMed ID: 19419975
[TBL] [Abstract][Full Text] [Related]
13. Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients.
Gardemann A; Humme J; Stricker J; Nguyen QD; Katz N; Philipp M; Tillmanns H; Hehrlein FW; Rau M; Haberbosch W
Thromb Haemost; 1998 Aug; 80(2):214-7. PubMed ID: 9716139
[TBL] [Abstract][Full Text] [Related]
14. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
[TBL] [Abstract][Full Text] [Related]
15. 4G/5G polymorphism and haplotypes of SERPINE1 in atherosclerotic diseases of coronary arteries.
Koch W; Schrempf M; Erl A; Mueller JC; Hoppmann P; Schömig A; Kastrati A
Thromb Haemost; 2010 Jun; 103(6):1170-80. PubMed ID: 20352162
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of the polymorphisms in the PAI-1 and IL-6 genes with smoking in determining their associated risk with coronary artery disease.
Sarecka B; Zak I; Krauze J
Clin Biochem; 2008 May; 41(7-8):467-73. PubMed ID: 18307986
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 polymorphism (4G/5G) predicts recurrence in nonhyperlipidemic postinfarction patients.
Corsetti JP; Ryan D; Moss AJ; Rainwater DL; Zareba W; Sparks CE
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):548-54. PubMed ID: 18096824
[TBL] [Abstract][Full Text] [Related]
18. [Platelet polymorphism and coronary artery disease].
Christiaens L; Macchi L; Duplantier C; Allal J; Brizard A; Barraine R; Coisne D
Arch Mal Coeur Vaiss; 2002 Mar; 95(3):173-8. PubMed ID: 11998331
[TBL] [Abstract][Full Text] [Related]
19. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects.
Deepa R; Velmurugan K; Saravanan G; Dwarakanath V; Agarwal S; Mohan V
J Assoc Physicians India; 2002 Jul; 50():901-6. PubMed ID: 12126344
[TBL] [Abstract][Full Text] [Related]
20. The contribution of platelet glycoproteins (GPIa C807T and GPIba C-5T) and cyclooxygenase 2 (COX-2G-765C) polymorphisms to platelet response in patients treated with aspirin.
Al-Azzam SI; Alzoubi KH; Khabour OF; Tawalbeh D; Al-Azzeh O
Gene; 2013 Sep; 526(2):118-21. PubMed ID: 23688555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]